HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

George Hsiao Selected Research

cephalochromin

4/2014Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


George Hsiao Research Topics

Disease

9Ischemia
03/2019 - 09/2002
9Brain Ischemia (Cerebral Ischemia)
09/2013 - 05/2004
9Infarction (Infarctions)
02/2012 - 09/2002
8Brain Injuries (Brain Injury)
09/2013 - 05/2004
7Neoplasms (Cancer)
05/2017 - 03/2010
7Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
09/2013 - 09/2005
6Neuroinflammatory Diseases
05/2021 - 11/2014
6Fibrosis (Cirrhosis)
01/2015 - 06/2009
6Thrombosis (Thrombus)
10/2005 - 04/2003
5Asthma (Bronchial Asthma)
05/2022 - 01/2010
5Hypoxia (Hypoxemia)
02/2012 - 03/2007
4Respiratory Hypersensitivity
05/2022 - 01/2013
4Inflammation (Inflammations)
01/2018 - 01/2010
4Pulmonary Embolism
06/2013 - 04/2003
4Reperfusion Injury
04/2013 - 09/2002
4Thromboembolism
12/2010 - 12/2003
3Endotoxemia
06/2019 - 08/2002
3Retinal Degeneration
04/2019 - 01/2017
3Cardiovascular Diseases (Cardiovascular Disease)
06/2013 - 01/2009
3Atherosclerosis
04/2011 - 08/2003
2Sepsis (Septicemia)
06/2019 - 06/2017
2Uveitis
03/2019 - 01/2018
2Fibrosarcoma
03/2018 - 02/2012
2Lung Neoplasms (Lung Cancer)
04/2014 - 04/2012
2Chondrosarcoma
04/2013 - 05/2011
2Ischemic Stroke
02/2012 - 04/2011
2Neoplasm Metastasis (Metastasis)
12/2011 - 05/2011
2Vascular Diseases (Vascular Disease)
12/2011 - 04/2006
2Hypertension (High Blood Pressure)
01/2009 - 01/2004
2Hypotension (Low Blood Pressure)
01/2009 - 08/2002
2Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
07/2008 - 02/2008
2Seizures (Absence Seizure)
09/2007 - 01/2004
2Myocardial Ischemia (Ischemic Heart Diseases)
09/2006 - 09/2002
2Ventricular Fibrillation
09/2006 - 09/2002
2Shock
04/2003 - 08/2002
1Pneumonia (Pneumonitis)
05/2022
1Retinal Neovascularization
07/2021
1Nervous System Diseases (Neurological Disorders)
05/2021
1Cerebral Hemorrhage
05/2021
1Cicatrix (Scar)
04/2021
1Diabetic Retinopathy (Retinopathy, Diabetic)
06/2020

Drug/Important Bio-Agent (IBA)

11Matrix Metalloproteinases (MMPs)IBA
06/2019 - 01/2009
9Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2015 - 03/2007
8Free RadicalsIBA
02/2012 - 08/2002
7CytokinesIBA
05/2022 - 01/2009
6Neuroprotective AgentsIBA
01/2019 - 04/2006
6Proteins (Proteins, Gene)FDA Link
01/2019 - 08/2003
6Caspase 3 (Caspase-3)IBA
02/2012 - 03/2007
5Retinaldehyde (Retinal)IBA
01/2020 - 01/2017
5Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
02/2012 - 04/2006
4Immunoglobulin E (IgE)IBA
05/2022 - 01/2013
4OvalbuminIBA
05/2022 - 01/2010
4LipopolysaccharidesIBA
06/2019 - 08/2002
4Adenosine Diphosphate (ADP)IBA
06/2013 - 04/2003
4Histone Deacetylase InhibitorsIBA
04/2012 - 05/2011
4Fluorescein (Funduscein)FDA LinkGeneric
10/2005 - 05/2003
3Interleukin-10 (Interleukin 10)IBA
05/2022 - 01/2010
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2021 - 01/2013
3Matrix Metalloproteinase 9 (Gelatinase B)IBA
06/2019 - 06/2017
3Histone Deacetylases (Histone Deacetylase)IBA
02/2012 - 05/2011
3theasinensin AIBA
02/2012 - 05/2011
3Therapeutic UsesIBA
04/2011 - 05/2004
3SolventsIBA
04/2011 - 05/2004
3tetramethylpyrazineIBA
03/2007 - 04/2006
3AntioxidantsIBA
03/2007 - 04/2003
2Interleukin-13IBA
05/2022 - 01/2013
2Interleukin-5 (Interleukin 5)IBA
05/2022 - 01/2013
2Retinal Pigments (Pigments, Visual)IBA
04/2019 - 01/2018
22,3,7,7a- tetrahydro- 3- hydroxy- 7- methyl- 2- (prop- 1- en- 1- yl)- 5H- furo(3,4- b)pyran- 5- oneIBA
03/2019 - 01/2018
2ethyl acetateIBA
03/2018 - 01/2017
2Anti-Allergic Agents (Antiallergic Agents)IBA
10/2017 - 01/2016
2imperatorinIBA
10/2017 - 01/2016
2Coloring Agents (Dyes)IBA
10/2015 - 08/2002
2SurvivinIBA
04/2014 - 02/2012
2andrographolideIBA
09/2013 - 12/2011
2Midazolam (Versed)FDA LinkGeneric
04/2013 - 03/2004
2Plasminogen Activator Inhibitor 1IBA
04/2012 - 06/2009
2trichostatin A (A 300)IBA
02/2012 - 05/2011
2sesamolIBA
05/2011 - 12/2010
2Messenger RNA (mRNA)IBA
01/2009 - 03/2007
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2009 - 08/2002
2Amyloid beta-PeptidesIBA
07/2008 - 02/2008
23-nitrotyrosineIBA
03/2007 - 04/2006
2Oxygen (Dioxygen)IBA
09/2006 - 09/2002
2Dihydrotachysterol (AT 10)IBA
04/2006 - 09/2002
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
10/2005 - 06/2005
2LycopeneIBA
10/2005 - 05/2004
2Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric
01/2004 - 05/2003
1acteosideIBA
05/2022
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
05/2022
1Interleukin-4 (Interleukin 4)IBA
05/2022
1indolineIBA
07/2021
1pro-matrix metalloproteinase 9IBA
04/2021
1EicosanoidsIBA
06/2020
1AlbuminsIBA
01/2020
111,12-epoxy-5,8,14-eicosatrienoic acidIBA
01/2020
1Tight Junction ProteinsIBA
01/2020

Therapy/Procedure

3Oral Administration
05/2022 - 01/2011
3Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2017 - 01/2011
2Therapeutics
05/2021 - 04/2011